Skip to main content

Published locations for FDA Approves First Targeted Therapy for Gliomas With IDH Mutations

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA Approves First Targeted Therapy for Gliomas With IDH Mutations

User login

  • Reset your password
  • /content/fda-approves-first-targeted-therapy-gliomas-idh-mutations
  • /neurologyreviews/article/270291/cns/brain-cancer/fda-approves-first-targeted-therapy-gliomas-idh
  • /oncologypractice/article/270291/cns/brain-cancer/fda-approves-first-targeted-therapy-gliomas-idh
  • /hematology-oncology/article/270291/cns/brain-cancer/fda-approves-first-targeted-therapy-gliomas-idh
  • /neurology/article/270291/cns/brain-cancer/fda-approves-first-targeted-therapy-gliomas-idh-mutations